Dupont Capital Management Corp Organon & Co. Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$31.66 - $38.9 $6,110 - $7,507	-193 Reduced 13.84%	1,202 $41,000
Q1 2022 Apr 27, 2022	BUY	$30.45 - $39.36 $20,584 - $26,607	676 Added 94.02%	1,395 $49,000
Q4 2021 Jan 31, 2022	SELL	$28.67 - $37.13 $15,940 - $20,644	-556 Reduced 43.61%	719 $22,000
Q3 2021 Nov 03, 2021	SELL	$28.63 - $35.64 $292,226 - $363,777	-10,207 Reduced 88.9%	1,275 $42,000
Q2 2021 Jul 30, 2021	BUY	$28.45 - $38.0 $326,662 - $436,316	11,482 New	11,482 $347,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.